Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockGet instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Home
Dashboard
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Ravinder Heights Ltd (RVHL) is currently trading at 38.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Ravinder Heights Limited operates in the real estate sector, focusing on acquisition, construction, and development of diverse infrastructure, including townships and commercial premises. The company was incorporated in April 2019 as a subsidiary of Panacea Biotec Limited, specializing in real estate projects and developments. In December 2020, the real estate business of Panacea Biotec Limited was demerged into Ravinder Heights, transitioning it from a subsidiary to an independent entity. Ravinder Heights engages in building infrastructure that spans residential, commercial, hospitality, and educational sectors, alongside regional infrastructure projects. The transition to an independent company involved a share allotment scheme whereby Panacea Biotec's shareholders received equivalent equity in Ravinder Heights.
Over the past 52 weeks, Ravinder Heights Ltd has traded between a low of ₹33.00 and a high of ₹71.43. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Ravinder Heights Ltd has a market capitalization of approximately 241.01. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Ravinder Heights Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 4.73 and operates in the Realty sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 241.01 Cr, Ravinder Heights Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Ravinder Heights Ltd operates in the Realty sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Ravinder Heights Ltd is 4.73. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Bearish
5
Neutral
6
Bullish
3
Bearish
36
Neutral
6
Bullish
4
Bearish
31
Neutral
0
Bullish
1
| Symbol | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
188.75 | 259 Cr | 47.07 | 6.00 | 0.00 | 12.67 | 11.55 | 2.68 | |
170.00 | 255 Cr | 19.34 | 2.28 | 0.59 | 8.52 | 13.51 | 6.12 | |
44.59 | 252 Cr | 27.36 | 0.87 | 0.00 | 4.22 | 8.75 | 2.68 | |
108.00 | 247 Cr | 5.93 | 0.64 | 0.00 | 8.22 | 5.75 | 5.49 | |
39.30 | 241 Cr | 4.73 | 0.66 | 0.00 | 10.29 | 13.76 | 13.87 | |
129.95 | 235 Cr | 40.36 | 3.60 | 0.00 | -0.21 | -0.06 | 8.61 | |
47.00 | 233 Cr | 32.19 | 2.82 | 0.00 | 9.56 | 6.74 | 0.95 |
Ravinder Heights Limited operates in the real estate sector, focusing on acquisition, construction, and development of diverse infrastructure, including townships and commercial premises.
The company was incorporated in April 2019 as a subsidiary of Panacea Biotec Limited, specializing in real estate projects and developments.
In December 2020, the real estate business of Panacea Biotec Limited was demerged into Ravinder Heights, transitioning it from a subsidiary to an independent entity.
Ravinder Heights engages in building infrastructure that spans residential, commercial, hospitality, and educational sectors, alongside regional infrastructure projects.
The transition to an independent company involved a share allotment scheme whereby Panacea Biotec's shareholders received equivalent equity in Ravinder Heights.
Realty
Construction - Factories / Offices / Commercial
241 Cr
High Risk
4.7
29.4
—
0.7
71.43
33.00
Sales CAGR
Profit CAGR
ROE
ROCE
